XML 33 R22.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Note 17 - Stockholders' Equity | 9 Months Ended
--- | ---
Sep. 30, 2017
Notes to Financial Statements |
Stockholders' Equity Note Disclosure [Text Block] | 1 7 . Stockholders’ Equity Total equity was $ 2.0 billion as of September 30, 2017, an increase of $140.2 million, from $1.8 billion as of December 31, 2016, primarily due to net income of $150.1 million and equity consideration for the acquisition of SinoPac Bancorp of $34.9 million partially offset by common stock cash dividends of $50.5 million and shares withheld related to net share settlement of RSUs of $5.1 million. The U.S. Treasury received warrants to purchase common stock of 1,846,374 shares at an exercise price of $20.96 as part of the Company ’s participation in the U.S. Treasury Troubled Asset Relief Program Capital Purchase Program. As a result of the anti-dilution adjustments under the warrant, the exercise price at December 31, 2016 has been adjusted to $20.65 and the number of warrants increased by 1.5%. At September 30, 2017, 932,461 warrants remain exercisable compared to 943,345 warrants at December 31, 2016. Activity in accumulated other comprehensive income, net of tax, and reclassification out of accumulated other comprehensive income for the three months and nine months ended September 30, 2017, and September 30, 2016, was as follows:
|  | Three months ended September 30, 2017 |  |  | Three months ended September 30, 2016 |
|  | Pre-tax |  |  | Tax expense/ (benefit) |  |  | Net-of-tax |  |  | Pre-tax |  |  | Tax expense/ (benefit) |  |  | Net-of-tax |
|  | (In thousands) |
Beginning balance, loss, net of tax |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities available-for-sale |  |  |  |  |  |  |  |  |  | $ | 1,001 |  |  |  |  |  |  |  |  |  |  | $ | 8,539 |
Cash flow hedge derivatives |  |  |  |  |  |  |  |  |  |  | (2,421 | ) |  |  |  |  |  |  |  |  |  |  | (7,397 | )
Total |  |  |  |  |  |  |  |  |  | $ | (1,420 | ) |  |  |  |  |  |  |  |  |  | $ | 1,142 |
Net unrealized (losses)/gains arising during the period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities available-for-sale |  | $ | 1,829 |  |  | $ | 769 |  |  | $ | 1,060 |  |  | $ | 1,618 |  |  | $ | 680 |  |  | $ | 938 |
Cash flow hedge derivatives |  |  | 271 |  |  |  | 114 |  |  |  | 157 |  |  |  | 1,387 |  |  |  | 583 |  |  |  | 804 |
Total |  |  | 2,100 |  |  |  | 883 |  |  |  | 1,217 |  |  |  | 3,005 |  |  |  | 1,263 |  |  | $ | 1,742 |
Reclassification adjustment for net losses in net income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities available-for-sale |  |  | (24 | ) |  |  | (10 | ) |  |  | (14 | ) |  |  | (1,692 | ) |  |  | (711 | ) |  |  | (981 | )
Cash flow hedge derivatives |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Total |  |  | (24 | ) |  |  | (10 | ) |  |  | (14 | ) |  |  | (1,692 | ) |  |  | (711 | ) |  |  | (981 | )
Total other comprehensive (loss)/income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities available-for-sale |  |  | 1,805 |  |  |  | 759 |  |  |  | 1,046 |  |  |  | (74 | ) |  |  | (31 | ) |  |  | (43 | )
Cash flow hedge derivatives |  |  | 271 |  |  |  | 114 |  |  |  | 157 |  |  |  | 1,387 |  |  |  | 583 |  |  |  | 804 |
Total |  | $ | 2,076 |  |  | $ | 873 |  |  | $ | 1,203 |  |  | $ | 1,313 |  |  | $ | 552 |  |  | $ | 761 |
Ending balance, (loss)/gain, net of tax |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities available-for-sale |  |  |  |  |  |  |  |  |  | $ | 2,047 |  |  |  |  |  |  |  |  |  |  | $ | 8,496 |
Cash flow hedge derivatives |  |  |  |  |  |  |  |  |  |  | (2,264 | ) |  |  |  |  |  |  |  |  |  |  | (6,593 | )
Total |  |  |  |  |  |  |  |  |  | $ | (217 | ) |  |  |  |  |  |  |  |  |  | $ | 1,903 |
|  | Nine months ended September 30, 2017 |  |  | Nine months ended September 30, 2016 |
|  | Pre-tax |  |  | Tax expense/ (benefit) |  |  | Net-of-tax |  |  | Pre-tax |  |  | Tax expense/ (benefit) |  |  | Net-of-tax |
|  | (In thousands) |
Beginning balance, loss, net of tax |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities available-for sale |  |  |  |  |  |  |  |  |  | $ | (1,545 | ) |  |  |  |  |  |  |  |  |  | $ | (5,431 | )
Cash flow hedge derivatives |  |  |  |  |  |  |  |  |  |  | (2,170 | ) |  |  |  |  |  |  |  |  |  |  | (2,995 | )
Total |  |  |  |  |  |  |  |  |  | $ | (3,715 | ) |  |  |  |  |  |  |  |  |  | $ | (8,426 | )
Net unrealized gains/(losses) arising during the period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities available-for sale |  | $ | 5,759 |  |  | $ | 2,421 |  |  | $ | 3,338 |  |  | $ | 27,170 |  |  | $ | 11,422 |  |  | $ | 15,748 |
Cash flow hedge derivatives |  |  | (162 | ) |  |  | (68 | ) |  |  | (94 | ) |  |  | (6,208 | ) |  |  | (2,610 | ) |  |  | (3,598 | )
Total |  |  | 5,597 |  |  |  | 2,353 |  |  |  | 3,244 |  |  |  | 20,962 |  |  |  | 8,812 |  |  | $ | 12,150 |
Reclassification adjustment for net (gains)/losses in net income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities available-for sale |  |  | 439 |  |  |  | 185 |  |  |  | 254 |  |  |  | (3,141 | ) |  |  | (1,320 | ) |  |  | (1,821 | )
Cash flow hedge derivatives |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Total |  |  | 439 |  |  |  | 185 |  |  |  | 254 |  |  |  | (3,141 | ) |  |  | (1,320 | ) |  |  | (1,821 | )
Total other comprehensive income/(loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities available-for sale |  |  | 6,198 |  |  |  | 2,606 |  |  |  | 3,592 |  |  |  | 24,029 |  |  |  | 10,102 |  |  |  | 13,927 |
Cash flow hedge derivatives |  |  | (162 | ) |  |  | (68 | ) |  |  | (94 | ) |  |  | (6,208 | ) |  |  | (2,610 | ) |  |  | (3,598 | )
Total |  | $ | 6,036 |  |  | $ | 2,538 |  |  | $ | 3,498 |  |  | $ | 17,821 |  |  | $ | 7,492 |  |  | $ | 10,329 |
Ending balance, gain/(loss), net of tax |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities available-for sale |  |  |  |  |  |  |  |  |  | $ | 2,047 |  |  |  |  |  |  |  |  |  |  | $ | 8,496 |
Cash flow hedge derivatives |  |  |  |  |  |  |  |  |  |  | (2,264 | ) |  |  |  |  |  |  |  |  |  |  | (6,593 | )
Total |  |  |  |  |  |  |  |  |  | $ | (217 | ) |  |  |  |  |  |  |  |  |  | $ | 1,903 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration